Radio Havana Cuba

A friendly voice around the world

  • Follow Us on

#NoMasBloqueo #SolidaridadVsBloqueo

Clinical Trial Begins in U.S. for Cuban Lung Cancer Vaccine

New York, January 7 (RHC-Agencies)-- Roswell Park Cancer Institute in Buffalo, New York, has launched the first clinical trial in the United States to study the CIMAvax-EGF vaccine, a lung cancer treatment that was developed in Cuba. Roswell Park is then the only facility in the United States that offers this groundbreaking treatment.

CIMAvax-EGF vaccine is a lung cancer treatment that was developed by researchers with the Havana-based Molecular Immunology Center. The medication is a type of therapy that harnesses the body’s immune system to fight lung cancer.

The current trial is a Phase I out of II study of the CIMAvax-EGF vaccine in combination with the Anti-PD1 checkpoint inhibitor nivolumab in patients previously treated for advanced non-small cell lung cancer (NSCLC).

Edited by Pavel Jacomino
Commentaries
MAKE A COMMENT
  • Cuban president calls for sensitivity in facing damage from Hurricane Michael
  • Fidel Castro: Our enemies' hatred grows as our Revolution strengthens
  • RHC's Caribbean Outlook Show
  • Good news from Guatemala
  • President Miguel Díaz-Canel says 150 years later Cuban Revolution is the same and so are its challenges
  • Cuba: The Revolution that began 150 years ago lives on today
NUMBER OF HITS/VISITORS

5237771

  • Max: 19729
  • yesterday: 3957
  • today: 3237
  • online: 136
  • total: 5237771